Clinical trial EV-301
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
| Cancers | |
|---|---|
| Organ | Ureters - bladder - urethra |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Astellas |
| EudraCT Identifier | 2017-003344-21 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03474107 |
| Inclusion criteria | Progression or relapse with anti-PD1 or anti-PD-L1 and platinum-based chemotherapy for locally advanced or metastatic urothelial carcinoma. |
| Last update |